Company
Every investor coverage indicates participated in a round ABN AMRO Morgans Corporate raised.
Companies ABN AMRO Morgans Corporate acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming ABN AMRO Morgans Corporate. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sunshine Heart has completed a $1.75 million share placement and announced a rights issue, with about $4.65 million pledged so far, including cornerstone commitments from CM Capital and GBS Venture Partners.
Cephalon has announced plans to buy out Arana Therapeutics shareholders at $1.40 a share, potentially $1.45, valuing the ASX-listed target around $318 million; its independent directors back the bid unless a better one emerges.